{"id":3076,"date":"2025-11-02T11:27:00","date_gmt":"2025-11-02T11:27:00","guid":{"rendered":"https:\/\/avelife.pro\/pharmacology-procurement-transformation-analytical-article\/"},"modified":"2025-12-12T17:39:45","modified_gmt":"2025-12-12T17:39:45","slug":"pharmacology-procurement-transformation-analytical-article","status":"publish","type":"post","link":"https:\/\/avelife.pro\/en\/pharmacology-procurement-transformation-analytical-article\/","title":{"rendered":"Pharmacology Procurement Transformation: analytical article"},"content":{"rendered":"\n<p>The pharmaceutical industry is undergoing a quiet but powerful \u201crethinking of the rules of the game.\u201d This phenomenon is now defined as pharmacology procurement transformation. It is not just a transition to electronic tools or cost reduction. It is a structural change in the logic by which companies plan, purchase, forecast, and control the supply of medicines, APIs, and laboratory materials.<\/p>\n\n<p>Below is an in-depth analysis: what is shaping the transformation, what technologies are driving the market, what risks are emerging, and what practices have already become the new standard.<\/p>\n\n<h2 class=\"wp-block-heading\">1. What is pharmacology procurement transformation?<\/h2>\n\n<p>This is a systemic modernization of procurement processes in pharmaceuticals, which combines:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>digitalization of the entire procurement cycle (from need to payment);<\/li>\n\n\n\n<li>using data and artificial intelligence for forecasting and inventory management;<\/li>\n\n\n\n<li>increasing the resilience of supply chains;<\/li>\n\n\n\n<li>transparent interaction with suppliers;<\/li>\n\n\n\n<li>integration of regulatory requirements into each stage.<\/li>\n<\/ul>\n\n<p>In essence, transformation means moving from a reactive model, where procurement only covers needs, to a strategic one, where procurement determines operational stability, competitive advantages, and even the availability of medicines on the market.<\/p>\n\n<h2 class=\"wp-block-heading\">2. Main drivers of transformation<\/h2>\n\n<h3 class=\"wp-block-heading\">1) Global supply chain disruptions<\/h3>\n\n<p>After the pandemic and geopolitical crises, the pharmaceutical market realized its critical dependence on:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>APIs from Asia, especially China and India;<\/li>\n\n\n\n<li>individual logistics corridors;<\/li>\n\n\n\n<li>single sources of raw materials.<\/li>\n<\/ul>\n\n<p>Procurement transformation has become the key to risk diversification.<\/p>\n\n<h3 class=\"wp-block-heading\">2) Regulatory pressure<\/h3>\n\n<p>Current regulations require:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>full traceability of the origin of components;<\/li>\n\n\n\n<li>quality transparency and GMP certification;<\/li>\n\n\n\n<li>compliance with environmental and ethical standards.<\/li>\n<\/ul>\n\n<p>Procurement must now be not just efficient, but also regulatory-proof.<\/p>\n\n<h3 class=\"wp-block-heading\">3) Economic factors<\/h3>\n\n<p>The pharmaceutical business operates in difficult conditions:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>rising costs of energy and logistics;<\/li>\n\n\n\n<li>competition between generics;<\/li>\n\n\n\n<li>price pressure from government tenders.<\/li>\n<\/ul>\n\n<p>Procurement should ensure not only quality, but also financial optimization without losing sustainability.<\/p>\n\n<h3 class=\"wp-block-heading\">4) Technological revolution<\/h3>\n\n<p>AI, big data analytics, automation, blockchain \u2014 all of these are no longer trends, but new standard tools.<\/p>\n\n<h2 class=\"wp-block-heading\">3. How exactly are procurements changing in pharmacology?<\/h2>\n\n<h3 class=\"wp-block-heading\">1. Transition to end-to-end digital platforms<\/h3>\n\n<p>Organizations are moving from Excel and fragmented ERP to:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>e-procurement systems (S2P \u2014 source-to-pay),<\/li>\n\n\n\n<li>centralized catalogs,<\/li>\n\n\n\n<li>automated contract control,<\/li>\n\n\n\n<li>digital tenders.<\/li>\n<\/ul>\n\n<p>This gives:<\/p>\n\n<p>fewer errors \u2192 faster approval \u2192 transparency \u2192 1-click audit.<\/p>\n\n<h3 class=\"wp-block-heading\">2. Using AI and predictive analytics<\/h3>\n\n<p>AI currently solves three key problems:<\/p>\n\n<ol class=\"wp-block-list\">\n<li>Demand forecast (especially for critical drugs and seasonal categories).<\/li>\n\n\n\n<li>Inventory optimization (reducing surplus + preventing shortages).<\/li>\n\n\n\n<li>Risk identification (delays, quality violations, unstable suppliers).<\/li>\n<\/ol>\n\n<p>Pharmaceutical companies that have implemented such systems reduce the number of critical shortages by 20\u201340%.<\/p>\n\n<h3 class=\"wp-block-heading\">3. Supplier partnership models<\/h3>\n\n<p>Transformation leads to supplier collaboration:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>joint volume planning;<\/li>\n\n\n\n<li>transparency of production facilities;<\/li>\n\n\n\n<li>business continuity agreements (BPA, framework contracts).<\/li>\n<\/ul>\n\n<p>Instead of one-time tenders, there are strategic relationships.<\/p>\n\n<h3 class=\"wp-block-heading\">4. Blockchain and Track &amp; Trace<\/h3>\n\n<p>Increasingly used:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>serialization of batches;<\/li>\n\n\n\n<li>confirmation of API origin;<\/li>\n\n\n\n<li>protection against counterfeiting;<\/li>\n\n\n\n<li>chain registers for GMP evidence.<\/li>\n<\/ul>\n\n<p>This increases trust and reduces regulatory risks.<\/p>\n\n<h3 class=\"wp-block-heading\">5. Total Cost of Ownership (TCO) Assessment<\/h3>\n\n<p>Companies no longer look only at the purchase price.<\/p>\n\n<p>Importantly:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>storage cost<\/li>\n\n\n\n<li>\u043b\u043e\u0433\u0456\u0441\u0442\u0438\u043a\u0430,<\/li>\n\n\n\n<li>risks from downtime,<\/li>\n\n\n\n<li>the cost of losing drug availability.<\/li>\n<\/ul>\n\n<p>TCO allows you to choose not the cheapest, but the most reliable and strategically beneficial.<\/p>\n\n<h2 class=\"wp-block-heading\">4. Main barriers to transformation<\/h2>\n\n<ol class=\"wp-block-list\">\n<li>Fragmented data \u2014 information scattered between ERP, laboratories, warehouse, and finance.<\/li>\n\n\n\n<li>Resistance to change in purchasing departments.<\/li>\n\n\n\n<li>Lack of competences in data-driven procurement<\/li>\n\n\n\n<li>High requirements for the quality of suppliers, especially when changing API sources.<\/li>\n\n\n\n<li>The cost of technology if there is no phased implementation strategy.<\/li>\n<\/ol>\n\n<h2 class=\"wp-block-heading\">5. Key effects of transformation<\/h2>\n\n<h3 class=\"wp-block-heading\">Benefits for pharmaceutical companies<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>reducing the risk of failures by 30\u201360%;<\/li>\n\n\n\n<li>reduction of stocks by 10\u201325%;<\/li>\n\n\n\n<li>faster completion of audits;<\/li>\n\n\n\n<li>reducing operating costs;<\/li>\n\n\n\n<li>improving quality and safety.<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Benefits for the state and healthcare systems<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>more sustainable availability of medicines;<\/li>\n\n\n\n<li>better transparency of tenders;<\/li>\n\n\n\n<li>minimizing counterfeiting.<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">6. Transformation Framework (3-stage model)<\/h2>\n\n<h3 class=\"wp-block-heading\">Stage 1 \u2014 Optimization<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>digital tenders, S2P platforms, data normalization;<\/li>\n\n\n\n<li>unification of contracts;<\/li>\n\n\n\n<li>KPI standardization.<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Stage 2 \u2014 Intelligent Automation<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>AI analytics;<\/li>\n\n\n\n<li>forecasting deficits;<\/li>\n\n\n\n<li>risk monitoring of suppliers.<\/li>\n<\/ul>\n\n<h3 class=\"wp-block-heading\">Stage 3 \u2014 Strategic Sustainability<\/h3>\n\n<ul class=\"wp-block-list\">\n<li>global diversification of supplies;<\/li>\n\n\n\n<li>blockchain-traceability;<\/li>\n\n\n\n<li>partnership models with manufacturers and laboratories.<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">7. KPIs that determine the success of transformation<\/h2>\n\n<ul class=\"wp-block-list\">\n<li>OTIF (on-time delivery)<\/li>\n\n\n\n<li>Days of Inventory Outstanding<\/li>\n\n\n\n<li>Share of positions with single-source risk<\/li>\n\n\n\n<li>Procurement cycle time<\/li>\n\n\n\n<li>Percentage of automated transactions<\/li>\n\n\n\n<li>Cost-to-Procure<\/li>\n\n\n\n<li>Supplier Risk Score<\/li>\n<\/ul>\n\n<h2 class=\"wp-block-heading\">8. Conclusion: why pharmacology procurement transformation is not a \u201cwish\u201d, but a requirement of the time<\/h2>\n\n<p>The pharmaceutical industry is entering a period where the safety and availability of medicines are becoming a matter of national security.<\/p>\n\n<p>The old procurement model\u2014reactive, fragmented, non-digital\u2014no longer works.<\/p>\n\n<p>Procurement transformation in pharmacology allows:<\/p>\n\n<ul class=\"wp-block-list\">\n<li>predict risks before they become a crisis;<\/li>\n\n\n\n<li>stabilize supply chains;<\/li>\n\n\n\n<li>reduce dependence on individual markets;<\/li>\n\n\n\n<li>ensure continuity of production;<\/li>\n\n\n\n<li>guarantee quality and trust.<\/li>\n<\/ul>\n\n<p>Pharmacology procurement transformation is a strategic foundation without which modern pharma cannot be competitive and sustainable.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pharmacology procurement transformation is a strategic foundation without which modern pharma cannot be competitive and sustainable.<\/p>\n","protected":false},"author":1,"featured_media":2968,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[309],"tags":[188,328,191,410,378],"class_list":["post-3076","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharmacology","tag-innovations-in-drug-development","tag-pharma","tag-pharmaceutical-technologies","tag-pharmacology-procurement-transformation-en","tag-trends2025"],"aioseo_notices":[],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/avelife.pro\/wp-content\/uploads\/2025\/12\/91f59f45-0d9d-4263-a011-b2e75baea563.png?fit=1536%2C1024&ssl=1","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts\/3076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/comments?post=3076"}],"version-history":[{"count":1,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts\/3076\/revisions"}],"predecessor-version":[{"id":3077,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/posts\/3076\/revisions\/3077"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/media\/2968"}],"wp:attachment":[{"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/media?parent=3076"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/categories?post=3076"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/avelife.pro\/en\/wp-json\/wp\/v2\/tags?post=3076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}